ZHAOKE OPHTH-B (06622.HK) has three glaucoma drugs approved for market release.

AASTOCKS · Dec 9, 2024 17:23

Zhaoke Ophthalmology-B (06622.HK) announced that three new glaucoma products, namely Latanoprost eye drops, Tafluprost eye drops, and Tafluprost eye drops, have been approved for market launch by the National Medical Products Administration, which is considered equivalent to passing the consistency evaluation of generic drugs. (vc/u)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

兆科眼科-B(06622.HK)三款青光眼藥物獲批上市

ZHAOKE OPHTH-B (06622.HK) has three glaucoma drugs approved for market release.

Risk Disclaimer

Statement